Emblem Appoints New CFO to Take Company through Next Phase of Growth
January 16 2018 - 11:44AM
NOT FOR DISTRIBUTION TO UNITED STATES
NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED
STATES.
Emblem Corp. (TSXV:EMC) (EMC.WT)
(“Emblem” or the
“Company”), is
pleased to announce the appointment of Alex Stojanovic as Chief
Financial Officer of the Company effective immediately. Mr.
Stojanovic will replace Mr. John Laurie who will be stepping down
going forward.
As CFO at Emblem, Mr. Stojanovic will be responsible for
ensuring the finance department can enable the Company to continue
to drive growth, capitalizing on the growing demand for premium
cannabis products across Emblem’s Medical, Pharmaceutical and
Recreational product verticals.
"First, on behalf of our entire team and the board of directors,
I would like to thank John for his dedication and contributions in
Emblem’s accomplishments thus far and wish him the best in the
future. Alex brings a strong background to our finance team from
his experience at other companies where he was instrumental in
providing the financial strategy and leadership to help the
organizations get to the next level of growth," said Nick Dean,
President and CEO of Emblem Corp. "With Alex, I'm confident we'll
be well positioned to meet our objectives concerning our capital
planning as we accelerate growth and build a leadership position
for our brand and products moving forward. We're excited to have
him on the Emblem team."
Mr. Stojanovic joined Emblem as Director of Finance in August,
2017. Previously, he held several senior finance positions in
Barrick Gold Corporation and Teranga Gold Corporation, including an
assignment in Chile overseeing the finance team on a multibillion
dollar construction project. Mr. Stojanovic has extensive
experience in external reporting and compliance, business planning,
capital markets activities, internal controls, corporate governance
and team development. He began his career in public accounting,
gaining valuable experience as an auditor and tax specialist. He
holds a Bachelor of Commerce degree from the University of Western
Ontario and is a Chartered Professional Accountant as well as a
Chartered Financial Analyst charter holder.
About EmblemEmblem Corp. is a fully integrated
licensed producer and distributor of medical cannabis and cannabis
derivatives in Canada under the ACMPR (Access to Cannabis for
Medical Purposes Regulations). Led by a team of cannabis experts
and former health care and pharma executives, it has three distinct
verticals – cannabis production, patient education centers, and
pharmaceutical dosage form development. Emblem trades under the
ticker symbol EMC on the Toronto Venture Exchange (TSXV).
For further information contact:
Ali Mahdavi Vice President, Capital Markets and Investor
Relations Emblem Corp. 416.962.3300 alimahdavi@emblemcorp.com
Forward-looking statements
This news release may contain “forward-looking information” and
“forward-looking statements” within the meaning of applicable
Canadian securities legislation (together, "forward-looking
statements"). All statements and information contained
herein that is not clearly historical in nature may constitute
forward-looking statement. Forward-looking statements are
necessarily based upon a number of estimates and assumptions that,
while considered reasonable by management, are inherently subject
to significant business, economic and competitive risks,
uncertainties and contingencies that may cause actual financial
results, performance or achievements to be materially different
from the estimated future results, performance or achievements
expressed or implied by those forward-looking statements.
Forward-looking statements are not a guarantee of future
performance and are subject to and involve a number of known and
unknown risks and uncertainties, many of which are beyond the
control of the Company, which may cause the Company's actual
performance and results to differ materially from any projections
of future performance or results expressed or implied by such
forward-looking statements. These risks and uncertainties include,
but are not limited to, the risks identified in the Company's
annual information form dated October 18, 2017 which has been filed
with the Canadian Securities Administrators and is available on
www.sedar.com. Any forward-looking statements are made as of the
date hereof and, except as required by law, the Company assumes no
obligation to publicly update or revise such statements to reflect
new information, subsequent or otherwise.
Readers are cautioned not to put undue reliance on these
forward-looking statements. This news release contains information
obtained by the Company from third parties and believes such
information to be accurate but has not independently verified such
information.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Emblem Corp (TSXV:EMC)
Historical Stock Chart
From Apr 2024 to May 2024
Emblem Corp (TSXV:EMC)
Historical Stock Chart
From May 2023 to May 2024